Wells Fargo’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,580
| Closed | -$340K | – | 7130 |
|
|
2024
Q2 | $340K | Buy |
12,580
+577
| +5% | +$12K | ﹤0.01% | 4160 |
|
|
2024
Q1 | $220K | Buy |
12,003
+1,391
| +13% | +$22.1K | ﹤0.01% | 4411 |
|
|
2023
Q4 | $130K | Buy |
10,612
+2,015
| +23% | +$18.9K | ﹤0.01% | 4741 |
|
|
2023
Q3 | $129K | Sell |
8,597
-8,502
| -50% | -$177K | ﹤0.01% | 4627 |
|
|
2023
Q2 | $556K | Buy |
17,099
+8,059
| +89% | +$294K | ﹤0.01% | 3873 |
|
|
2023
Q1 | $354K | Buy |
9,040
+7,211
| +394% | +$353K | ﹤0.01% | 4074 |
|
|
2022
Q4 | $96.7K | Buy |
1,829
+209
| +13% | +$10.2K | ﹤0.01% | 4543 |
|
|
2022
Q3 | $73K | Sell |
1,620
-1,755
| -52% | -$75.5K | ﹤0.01% | 4772 |
|
|
2022
Q2 | $123K | Sell |
3,375
-37,681
| -92% | -$1.37M | ﹤0.01% | 4531 |
|
|
2022
Q1 | $1.7M | Sell |
41,056
-13,813
| -25% | -$486K | ﹤0.01% | 3452 |
|
|
2021
Q4 | $2.34M | Sell |
54,869
-125,637
| -70% | -$6.29M | ﹤0.01% | 3340 |
|
|
2021
Q3 | $9.93M | Buy |
180,506
+31,279
| +21% | +$1.64M | ﹤0.01% | 2221 |
|
|
2021
Q2 | $7.14M | Sell |
149,227
-21,752
| -13% | -$1.11M | ﹤0.01% | 2522 |
|
|
2021
Q1 | $8.66M | Sell |
170,979
-48,496
| -22% | -$2.7M | ﹤0.01% | 2321 |
|
|
2020
Q4 | $13.8M | Buy |
219,475
+329
| +0.2% | +$20.4K | ﹤0.01% | 1829 |
|
|
2020
Q3 | $14.7M | Buy |
219,146
+830
| +0.4% | +$45.3K | ﹤0.01% | 1612 |
|
|
2020
Q2 | $9.14M | Buy |
218,316
+43,083
| +25% | +$1.65M | ﹤0.01% | 1925 |
|
|
2020
Q1 | $5.52M | Sell |
175,233
-2,154,399
| -92% | -$86.3M | ﹤0.01% | 2156 |
|
|
2019
Q4 | $94.1M | Buy |
2,329,632
+1,253,220
| +116% | +$43.9M | 0.03% | 598 |
|
|
2019
Q3 | $35M | Buy |
1,076,412
+949,519
| +748% | +$37.8M | 0.01% | 1097 |
|
|
2019
Q2 | $6.15M | Buy |
+126,893
| New | +$5.4M | ﹤0.01% | 2385 |
|
Other funds holding SILK
Wells Fargo's SILK Position: Q3 2024 in Review
Wells Fargo sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 12,580 shares — an estimated $340K sold.
Wells Fargo first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $94.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Wells Fargo reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Wells Fargo sold 12,580 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $340K.
- Wells Fargo first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- Wells Fargo's Silk Road Medical, Inc. Common Stock position peaked at $94.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.